XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026)
XORTX Therapeutics (XRTX) posted Operating Expenses of $139937.0 for Q1 2026, down 0.56% on a QoQ basis from $140728.0 in Q3 2025.
XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Operating Expenses history runs 7 years deep, the most recent figure standing at $139937.0 for Q1 2026.
- Quarterly Operating Expenses changed N/A year-over-year to $139937.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280665.0 (up 90.5% YoY) and the FY2025 annual result came in at $670131.4, up 41.99% from the prior year.
- Operating Expenses was $139937.0 for Q1 2026 at XORTX Therapeutics, down from $140728.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $1.6 million in Q1 2022 and bottomed at -$1.8 million in Q4 2023.
- A 5-year average of $570495.0 and a median of $599718.3 in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 8325.33% — and 2023, when it sank 220.76%.
- XORTX Therapeutics' Operating Expenses stood at $1.5 million in 2022, then sank by 220.76% to -$1.8 million in 2023, then jumped by 108.19% to $147329.0 in 2024, then retreated by 4.48% to $140728.0 in 2025, then declined by 0.56% to $139937.0 in 2026.
- Business Quant data shows XRTX's Operating Expenses at $139937.0 in Q1 2026, $140728.0 in Q3 2025, and $147329.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 139,937.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139,937.00 |
| Sep 30, 2025 | 140,728.00 |
| Sep 30, 2024 | 147,329.00 |
| Dec 31, 2023 | -1.80 Mn |
| Sep 30, 2023 | 526,384.48 |
| Jun 30, 2023 | 599,718.25 |
| Mar 31, 2023 | 884,541.49 |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 457,723.19 |
| Sep 30, 2021 | 308,413.53 |
| Jun 30, 2021 | 39,435.00 |
| Mar 31, 2021 | 19,434.86 |
| Dec 31, 2020 | 110,824.83 |
| Sep 30, 2020 | 91,382.84 |